Emergent BioSolutions | EBS - Employees Total Number


Emergent BioSolutions reported 1.6K in Employees for its fiscal year ending in December of 2023.





Employees Change Date
Acadia Pharmaceuticals 653 56 Dec/2024
Akebia Therapeutics 167 37 Dec/2023
ALKERMES 1.8K 300 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amarin 275 90 Dec/2023
ANI Pharmaceuticals 642 42 Dec/2023
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Coherus Biosciences 306 53 Dec/2023
Emergent BioSolutions 1.6K 900 Dec/2023
Exelixis 1.15K 163 Dec/2025
Glaxosmithkline GBP 69.4K 20.7K Dec/2022
Heron Therapeutics 126 77 Dec/2023
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Ironwood Pharmaceuticals 267 48 Dec/2023
Lexicon Pharmaceuticals 285 150 Dec/2023
Lonza 17.49K 1.28K Dec/2022
Merck 75K 3K Dec/2024
Moderna 5.8K 200 Dec/2024
Myriad Genetics 2.7K 0 Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Neurocrine Biosciences 1.8K 400 Dec/2024
Pacira 790 79 Dec/2024
Pfizer 81K 7K Dec/2024
PTC Therapeutics 939 49 Dec/2024
Sanofi 84.59K 3.41K Dec/2024
Sarepta Therapeutics 1.37K 58 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023